ARCHIVES

Agency Approves Two Pairs Of Drugs and Diagnostic Tests

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

Pathology In Operating Suite Cuts Need for More Surgery

February 24, 2012

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

OCC Has Answers Ready Or Most Questions Asked

March 21, 1980

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

In Brief: Ford To Go Along With Cooper As Health Chief, Fredrickson As NIH Director, W.H. Sources Says

March 14, 1975